DIFFERENT EFFECTS OF ATORVASTATIN AND ROSUVASTATIN ON CIRCULATING MICRORNAS-126 AND 146A LEVELS IN PATIENTS WITH CORONARY ARTERY DISEASE WITH TYPE 2 DIABETES MELLITUS

被引：0
作者：
Serik, S. [1 ]
Riabukha, V. [1 ]
Mavrycheva, N. [1 ]
Malko, V. [1 ]
Bondar, T. [2 ]
机构：
[1] Natl Acad Med Sci Ukraine, Dept Ischem Heart Dis Metab & Cardiopulmonary Dis, LT Malaya Therapy Natl Inst, Kharkiv, Ukraine
[2] Natl Acad Med Sci Ukraine, LT Malaya Therapy Natl Inst, Lab Immuno Biochem & Mol Genet Res, Kharkiv, Ukraine
来源：
ATHEROSCLEROSIS | 2023年 / 379卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P429
引用
收藏
页码：S139 / S140
页数：2
相关论文
共 50 条
  • [21] The effects of long-term atorvastatin treatment on endothelial function in patients with coronary artery disease and diabetes mellitus type II
    Chumburidze, S. H.
    Shavdatuashvili, T.
    Shelia, G.
    EUROPEAN HEART JOURNAL, 2010, 31 : 100 - 100
  • [22] Analysis of circulating ceramides and hexosylceramides in patients with coronary artery disease and type II diabetes mellitus
    Duesing, Philip
    Heinrich, Nadine N.
    Al-Kassou, Baravan
    Gutbrod, Katharina
    Doermann, Peter
    Nickenig, Georg
    Jansen, Felix
    Zietzer, Andreas
    BMC CARDIOVASCULAR DISORDERS, 2023, 23 (01)
  • [23] Comparision of Effects of Rosuvastatin Versus Atorvastatin Treatment on Plasma Levels of Asymmetric Dimethylarginine in Hyperlipidemic Patients with Coronary Artery Disease
    Kurtoglu, E.
    Balta, S.
    Sincer, I.
    Altas, Y.
    Atas, H.
    Yilmaz, M.
    Korkmaz, H.
    Erdem, K.
    Akturk, E.
    Demirkol, S.
    Can, C.
    AMERICAN JOURNAL OF CARDIOLOGY, 2014, 113 (07) : S13 - S13
  • [24] Analysis of circulating ceramides and hexosylceramides in patients with coronary artery disease and type II diabetes mellitus
    Philip Düsing
    Nadine N. Heinrich
    Baravan Al-Kassou
    Katharina Gutbrod
    Peter Dörmann
    Georg Nickenig
    Felix Jansen
    Andreas Zietzer
    BMC Cardiovascular Disorders, 23
  • [25] Optimal care of patients with type 2 diabetes mellitus and coronary artery disease
    Frye, RL
    AMERICAN JOURNAL OF MEDICINE, 2003, 115 : 93 - 98
  • [26] Antithrombotic therapy in patients with coronary artery disease and with type 2 diabetes mellitus
    Farhan, Serdar
    Hochtl, Thomas
    Kautzky-Willer, Alexandra
    Wojta, Johann
    Huber, Kurt
    WIENER MEDIZINISCHE WOCHENSCHRIFT, 2010, 160 (1-2) : 30 - 38
  • [27] Screening for asymptomatic coronary artery disease in patients with type 2 diabetes mellitus
    Tavares, Carlos Augusto F.
    Wajchjenberg, Bernardo Leo
    Rochitte, Carlos
    Lerario, Antonio Carlos
    ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2016, 60 (02): : 143 - 151
  • [28] Screening of the silent coronary artery disease in patients with type 2 diabetes mellitus
    Begic, A. A. B.
    Dzubur, M. M. D.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S272 - S272
  • [29] Screening for coronary artery disease in asymptomatic patients with type 2 diabetes mellitus
    SHEN Weifeng Department of CardiologyRuijin HospitalShanghai Jiao Tong University School of MedicineShanghai China
    ChineseMedicalJournal, 2007, 120 (21) : 1859 - 1861
  • [30] THE ROLE OF POSTPRANDIAL GLYCEMIA IN THE EFFECTIVENESS OF ROSUVASTATIN IN PATIENTS WITH CORONARY ARTERY DISEASE AND TYPE 2 DIABETES
    Trigulova, Raisa
    Mukhtarova, Shachnoza
    Alimova, Dilnoza
    ATHEROSCLEROSIS, 2024, 395
12345